- Most Recent Funding
- $500 Thousand Debt Financing on January 3, 2011
Aarden Pharmaceuticals, Inc. operates as a small molecule drug discovery and development company. It develops drugs targeting the phosphatase family of proteins with emphasis on protein tyrosine phosphatases that catalyze the removal of phosphate groups from tyrosine residues of proteins and play key roles along with the tyrosine kinases in various signal transduction pathways. The company’s drug programs focus on infectious diseases, cancer, metabolic, and autoimmune therapeutic areas. Aarden Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Indianapolis, Indiana.
351 West 10th Street
Indianapolis, IN 46202